Brigitte Picard

Dr. Brigitte Picard

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2014 in European Journal of Histochemistry
Verified
Journal Article
Open access
PDF file
MKM. Kammoun
M. Kammoun
ICIsabelle Cassar-Malek
Isabelle Cassar-Malek
BMB. Meunier
B. Meunier
BPBrigitte Picard
Brigitte Picard
A simplified immunohistochemical classification of skeletal muscle fibres in mouse

22 July 2015 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
Mohammed GagaouaMohammed Gagaoua
Mohammed Gagaoua
CTClaudia Terlouw
Claudia Terlouw
DMDidier Micol
Didier Micol
ABAbdelghani Boudjellal
Abdelghani Boudjellal
Jean-Francois HOCQUETTEJean-Francois HOCQUETTE
Jean-Francois HOCQUETTE
BPBrigitte Picard
Brigitte Picard

1 November 2015 in Meat Science
Verified
Journal Article
Closed access
BPBrigitte Picard
Brigitte Picard
BLB. Lebret
B. Lebret
ICIsabelle Cassar-Malek
Isabelle Cassar-Malek
LLL. Liaubet
L. Liaubet
CBC. Berri
C. Berri
GRG. Renand
G. Renand

1 October 2015 in Journal of Proteomics
Verified
Journal Article
Closed access
Mohammed GagaouaMohammed Gagaoua
Mohammed Gagaoua
CTClaudia Terlouw
Claudia Terlouw
ABAbdelghani Boudjellal
Abdelghani Boudjellal
BPBrigitte Picard
Brigitte Picard

27 April 2009 in BMC Genomics
Verified
Journal Article
Open access
PDF file
ICIlham Chelh
Ilham Chelh
BMBruno Meunier
Bruno Meunier
BPBrigitte Picard
Brigitte Picard
JRJames Reecy
James Reecy
CCCatherine Chevalier
Catherine Chevalier
ICIsabelle Cassar-Malek
Isabelle Cassar-Malek
Background: Myostatin (MSTN), a member of the TGF-β superfamily, has been identified as a negative regulator of skeletal muscle mass. Inactivating mutations in the MSTN gene are responsible for the development of a hypermuscular phenotype. In this study, we performed transcriptomic and proteomic analyses to detect altered expression/abundance of genes and proteins. These differentially expressed genes and proteins may represent new molecular targets of MSTN and could be involved in the regulation of skeletal muscle mass. Results: Transcriptomic analysis of the Quadriceps muscles of 5-week-old MSTN-null mice (n = 4) and their controls (n = 4) was carried out using microarray (human and murine oligonucleotide sequences) of 6,473 genes expressed in muscle. Proteomic profiles were analysed using two-dimensional gel electrophoresis coupled with mass spectrometry. Comparison of the transcriptomic profiles revealed 192 up- and 245 down- regulated genes. Genes involved in the PI3K pathway, insulin/IGF pathway, carbohydrate metabolism and apoptosis regulation were up-regulated. Genes belonging to canonical Wnt, calcium signalling pathways and cytokine-receptor cytokine interaction were down-regulated. Comparison of the protein profiles revealed 20 up- and 18 down-regulated proteins spots. Knockout of the MSTN gene was associated with up-regulation of proteins involved in glycolytic shift of the muscles and down-regulation of proteins involved in oxidative energy metabolism. In addition, an increased abundance of survival/anti-apoptotic factors were observed. Conclusion: All together, these results showed a differential expression of genes and proteins related to the muscle energy metabolism and cell survival/anti-apoptotic pathway (e.g. DJ-1, PINK1, 14-3-3ε protein, TCTP/GSK-3β). They revealed the PI3K and apoptotic pathways as MSTN targets and are in favour of a role of MSTN as a modulator of cell survival in vivo.

1 October 2012 in Animal Frontiers
Verified
Journal Article
Open access
PDF file
BPBrigitte Picard
Brigitte Picard
FLF. Lefèvre
F. Lefèvre
BLB. Lebret
B. Lebret
Copyright © 2012. . © 2012 Picard, Lefèvre and Lebret